Unverified50% confidenceFactExact time
The life sciences AI track includes protein structure prediction represented by DeepMind's AlphaFold series, computational drug discovery represented by Schrödinger and Insilico Medicine, and general research assistants, among other categories.
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
10/20/2026
First Seen
Valid until: 1/18/2027
Sources
Related Entities
Related Claims
Unverified模型驱动搜索范式后来影响了从蛋白质折叠（AlphaFold）到数学定理证明（AlphaProof）的一系列突破69% similarUnverifiedIn February 2026, Isomorphic Labs released the Drug Design Engine (IsoDDE), and a technical report states that its performance on protein-ligand structure prediction is twice that of AlphaFold 3, its binding affinity prediction accuracy is higher than physics-based methods, and its time and cost are far lower than the latter.68% similarUnverifiedThe widespread adoption of high-throughput inference runtimes will gradually make proteome-scale structural analysis a standard starting point for life sciences research.67% similarUnverifiedAlphaFold2 emerged in 2021, dramatically improving protein structure prediction accuracy; RFdiffusion was developed by David Baker's team and uses a diffusion model to directly sample in structure space.63% similarUnverifiedAlphaFold was developed by DeepMind and achieved accuracy comparable to experimental methods in the 2020 CASP14 competition, and is regarded as one of the most significant breakthroughs in structural biology in fifty years.62% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1077858API
curl https://kongchang.com/api/v1/knowledge/claims/1077858MCP
get_claim(id=1077858)